ev3 (EVVV) Director Buys 50K Shares
More News related to EVVV
- Anulex Technologies, Inc. Appoints Richard Lunsford as President and Chief Executive Officer
- Vertos Medical, Inc. Appoints James M. Corbett Chief Executive Officer
- Caris Downgrades ev3 (EVVV) to Above Average
- ev3 (EVVV) Reports Q3 Adj-EPS of $0.04
- ev3 Inc. Reports Third Quarter 2008 Financial Results
More News related to Insider Trades
- Friedman Billings Starts Aircastle (AYR) at Underperform
- Friedman Billings Starts Netflix (NFLX) at Market Perform
- Credit Suisse Starts 3PAR (PAR) at Neutral
- Credit Suisse Starts Netezza (NZ) at Neutral
- FBR Starts Amazon.com (AMZN) at Market Perform
ev3, Inc. (Nasdaq: EVVV) Director, Daniel Lavangie, bought 50,000 shares on 8/5-8/6 at prices from $10.43-$10.89.
ev3, Inc., a medical device company, focuses on catheter-based technologies for the endovascular treatment of vascular diseases and disorders.
Related Categories
Insider TradesStocks Mentioned
-0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
